In brief: Henry Schein makes CGM play, diabetes tech integrates, Medicare overpays & more
MELVILLE, N.Y. - Henry Schein has signed an agreement to buy Tampa, Fla.-based Acentus, a national supplier specializing in delivering continuous glucose monitors (CGMs) with $35 million in annual revenue. Along with its previous acquisitions of Prism …